Deadline Soon: Open Lending Corporation (LPRO) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
LOS ANGELES--(BUSINESS WIRE)-- The Law Offices of Frank R. Cruz reminds investors of the upcoming June 30, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Open Lending Corporation ('Open Lending' or the 'Company') (NASDAQ: LPRO) securities between , inclusive (the 'Class Period').
IF YOU ARE AN INVESTOR WHO LOST MONEY ON OPEN LENDING CORPORATION (LPRO), CLICK HERE TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT.
What Happened?
On March 17, 2025, before the market opened, Open Lending disclosed that it would be unable to timely file its Annual Report for 2024 as it 'require[d] additional time to finalize its accounting and review processes specifically related to its profit share revenue and related contract assets.'
On this news, the Company's share price fell $0.40, or 9.28%, to close at $3.91 per share on March 17, 2025, on unusually heavy trading volume. The stock continued to fall the following trading day, declining $0.42, or 10.87%, to close at $3.49 on March 18, 2025, on unusually heavy trading volume.
Then, on March 31, 2025, after the market closed, Open Lending released its fourth quarter and full year 2024 financial results, revealing quarterly revenue of negative $56.9 million due in part to 'a $81.3 million reduction in estimated profit share revenues related to business in historic vintages' … 'primarily due to heightened delinquencies and corresponding defaults associated with loans originated in 2021 through 2024.' The Company identified 'three factors primarily contributed to this reduction of estimated profit share.' First, a 'deterioration of the Company's 2021 and 2022 vintages' resulting in loans which were 'worth significantly less than their corresponding outstanding loan balances.' This factor accounted for 'approximately 40% of the Company's total negative change.' Second, the Company 'identified two cohorts of borrowers, borrowers with credit builder tradelines and borrowers with fewer positive tradelines, that caused its 2023 and 2024 vintages to underperform.' This factor 'accounted for approximately 40% of the Company's total negative change.' Third, the Company revealed 'continued elevated delinquencies and ultimate defaults' which 'accounted for approximately 20% of the Company's total negative change.' Additionally, the Company disclosed a net loss of $144 million, due to the Company being 'negatively impacted by the recording of a valuation allowance on [its] deferred tax assets of $86.1 million, which increased [its] income tax expense during the period.'
In a separate press release, the Company also announced that it had appointed a new Chief Executive Officer and a new Chief Operating Officer, effective immediately, both of whom would be replacing Charles D. Jehl, who had been operating as the Company's Chief Executive Officer, Chief Operating Officer and Chief Financial Officer simultaneously.
On this news, the Company's share price fell $1.59 or 57.61%, to close at $1.17 per share on April 1, 2025, on unusually heavy trading volume.
What Is The Lawsuit About?
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants: (1) misrepresented the capabilities of the Company's risk-based pricing models; (2) issued materially misleading statements regarding the Company's profit share revenue; (3) failed to disclose the Company's 2021 and 2022 vintage loans had become worth significantly less than their corresponding outstanding loan balances; (4) misrepresented the underperformance of the Company's 2023 and 2024 vintage loans; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
If you purchased or otherwise acquired Open Lending securities between February 24, 2022 and March 31, 2025, the deadline to seek appointment as the lead plaintiff in the securities fraud class action is June 30, 2025.
Contact Us To Participate or Learn More:
If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact us:
Frank R. Cruz
The Law Offices of Frank R. Cruz,
2121 Avenue of the Stars, Suite 800,
Century City, California 90067
Email us at: info@frankcruzlaw.com
Call us at: 310-914-5007
Visit our website at www.frankcruzlaw.com
Follow us for updates on Twitter: twitter.com/FRC_LAW
If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
Armanino Foods of Distinction, Inc. Doug Nichols to Retire as Chairman of Armanino Foods
BUSINESS WIRE)--Armanino Foods of Distinction, Inc. (OTCQX: AMNF) today announced that Doug Nichols, longtime Director and Chairman of the Board, will retire effective August 15, 2025. Mr. Nichols has been a shareholder since 1992, a Board member since 2001, and has served as Chairman since 2009, succeeding Company founder William J. Armanino. During Mr. Nichols' 24-year tenure on the Board, Armanino Foods delivered a total shareholder return of over 12,200% including dividends and dividends reinvested, representing a compound annual growth rate of 22%. Mr. Nichols was primarily responsible for initiating the Company's quarterly dividend program, which recently marked its 100th consecutive quarterly payment. He was also a catalyst and a driving force behind all 11 special dividends declared before and during his time on the Board, underscoring the Company's consistent shareholder-focused philosophy. Nichols also spearheaded the launch of Armanino's initial share repurchase program many years ago and has remained a strong supporter of the Company's current ongoing buyback strategy. 'We started with specials because we didn't want to disappoint shareholders if we couldn't sustain it,' said Nichols. 'That was before I joined the Board, but I was a catalyst on all of them, too. After 100 consecutive quarterly dividends paid, I am very proud of our track record!' Mr. Nichols led the Company through sustained growth, expanded operations, and enhanced governance practices. He has long championed conservative financial management and consistent shareholder returns. Reflecting on his retirement, Nichols added: 'First and foremost, I'd like to remember company founder William Armanino, longtime CEO Edward Pera, current Board member Debbie Armanino LeBlanc, and longtime company counsel Mark Cassanego. They've all been good buddies, and between us, we've run a pretty good food company. I certainly wasn't the food expert!' He also praised current and recent Board members: 'James Ford's energy and business knowledge have been indispensable to me as I've planned my retirement. John Micek has been a steadying force as an advisor and Audit Chair. I can never thank Al Banisch enough for chairing the compensation committee these last few years. And Tony Muscato has brought a level of food company operational expertise that has significantly elevated the Board's ability to assist management.' Nichols offered special recognition to the Company's new CEO: 'Deanna Jurgens has brought a new level of enthusiasm that's hard for me to keep up with. She is a fantastic, creative, talented, and disciplined leader. It's a very, very exciting time for Armanino Foods.' He concluded: 'This is the best management and board team we've ever had. It's a great time for an old guy to move on—as it's time-consuming just trying to keep up! I will miss seeing all my friends. The shareholders are in very, very good hands.' Mr. Nichols will remain a significant shareholder and supporter of the Company. The Board of Directors expects to announce succession plans soon. Armanino Foods of Distinction, Inc. is an international food company that manufactures and markets frozen Italian specialty food items such as pestos, sauces and filled pastas to the foodservice, retail, and industrial markets. In addition to a classic Basil Pesto, Armanino offers other flavors such as Cilantro, Dried Tomato & Garlic, Roasted Red Bell Pepper, Southwest Chipotle, Artichoke, Roasted Garlic, Light Basil Pesto, Chimichurri, Harissa, Bolognese, Alfredo sauce, Creamy Garlic, and Romesco. Armanino's organic line includes classic Basil Pesto. Armanino Foods also offers cheese shakers, frozen pastas, meatballs, and prepared meals. Cautionary Statements Regarding Forward-Looking Information: The declaration of cash dividends in the future, pursuant to the Company's dividend policy, is subject to final determination each quarter by the Board of Directors based on a number of factors, including the Company's financial performance and its available cash resources. For this reason, as well as others, there can be no assurance that dividends in the future will be equal or similar to the amount described in this press release or that the Board of Directors will not decide to suspend or discontinue the payment of cash dividends in the future. Statements in this news release regarding our expectations and beliefs about our future financial performance and trends in our markets are 'forward- looking statements' as defined in the Private Securities Litigations Reform Act of 1995. Forward-looking statements often include the words 'believe,' 'expect,' 'anticipate,' 'intend,' 'plan,' 'estimate,' 'project,' or words of similar meaning, or future or conditional verbs such as 'will,' 'would,' 'should,' 'could,' or 'may.' The forward-looking statements in this news release regarding our future financial performance are based on current information and because our business is subject to several risks and uncertainties, actual operating results in the future may differ significantly from the future financial performance expected at the current time. Those risks and uncertainties may include, among others: economic factors affecting consumer confidence and discretionary spending and reducing the consumption of food prepared away from home; the extent and duration of the negative impact of the COVID-19 pandemic and its consequences on the Company; cost inflation/deflation and commodity volatility; competition; reliance on third party suppliers and interruption of product supply or increases in product costs; changes in the Company's relationships with customers and group purchasing organizations; the Company's ability to increase or maintain the highest margin portions of the Company's business; achievement of expected benefits from cost savings initiatives; increases in fuel costs; changes in consumer eating habits; cost and pricing structures and other governmental regulation, including actions taken by national, state and local governments to contain and/or respond to the COVID-19 pandemic and its consequences; product recalls and product liability claims; and our reputation in the industry. The forward-looking statements contained in this press release speak only as of the date of this press release and are based on information and estimates available to the Company at this time. We undertake no obligation to update or revise any forward-looking statements, except as may be required by law.
Business Wire
an hour ago
- Business Wire
Perfect Moment Ltd. Announces Proposed Public Offering of Common Stock
LONDON--(BUSINESS WIRE)--Perfect Moment Ltd. (NYSE American: PMNT) ('Perfect Moment' or the 'Company'), the high-performance, luxury skiwear and lifestyle brand that fuses technical excellence with fashion-led designs, today announced that it intends to offer to sell shares of its common stock in an underwritten public offering. All of the shares of common stock are to be sold by the Company. ThinkEquity is acting as sole book-running manager for the offering. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. The Company intends to use the net proceeds from the offering for repayment of debt, working capital and general corporate purposes. The securities in the offering will be offered and sold pursuant to a shelf registration statement on Form S-3 (File No. 333-285612), including a base prospectus, filed with the U.S. Securities and Exchange Commission (the 'SEC') on March 6, 2025 and declared effective on March 12, 2025. The offering will be made only by means of a written prospectus. A preliminary prospectus supplement and accompanying prospectus describing the terms of the offering has been or will be filed with the SEC on its website at Copies of the preliminary prospectus supplement and the accompanying prospectus relating to the offering may also be obtained from the offices of ThinkEquity, 17 State Street, 41 st Floor, New York, New York 10004. Before investing in the offering, interested parties should read in their entirety the preliminary prospectus supplement and the accompanying prospectus and the other documents that the Company has filed with the SEC that are incorporated by reference in such preliminary prospectus supplement and the accompanying prospectus, which provide more information about the Company and such offering. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. About Perfect Moment Ltd. Founded in Chamonix, France, Perfect Moment is a luxury outerwear and activewear brand that merges alpine heritage with fashion-forward performance. Known for its technical excellence, bold design, and versatile pieces that transition seamlessly from slopes to city, the brand is worn by athletes, tastemakers, and celebrities worldwide. Perfect Moment is traded on the NYSE American under the ticker symbol PMNT. Learn more at Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as 'anticipate,' 'believe,' 'contemplate,' 'could,' 'estimate,' 'expect,' 'intend,' 'seek,' 'may,' 'might,' 'plan,' 'potential,' 'predict,' 'project,' 'target,' 'aim,' 'should,' 'will,' 'would,' or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based on our current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ from those contained in the forward-looking statements, include those risks and uncertainties described more fully in the sections titled 'Risk Factors' in our Form 10-K for the fiscal year ended March 31, 2024, and in the prospectus supplement for the offering, filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release are made as of this date and are based on information currently available to us. We undertake no duty to update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
Business Wire
an hour ago
- Business Wire
Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements
BURLINGTON, Mass.--(BUSINESS WIRE)-- Bone Biologics Corporation ('Bone Biologics' or the 'Company') (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced that it has received notice from The Nasdaq Stock Market LLC ('Nasdaq') informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the 'Rule') for continued listing on the Nasdaq Capital Market. Bone Biologics is now in compliance with all applicable listing standards and its common stock will continue to be listed on the Nasdaq Capital Market. Bone Biologics was notified by Nasdaq on April 7, 2025 that it was not in compliance with the Rule because its common stock failed to meet the closing bid price of $1.00 or more for 30 consecutive business days. In order to regain compliance with the Rule, the Company was required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive trading days. This requirement was met on June 24, 2025, the 10 th consecutive trading day when the closing bid price of the Company's common stock was over $1.00. About Bone Biologics Bone Biologics was founded to pursue regenerative medicine for bone. The Company is undertaking work with select strategic partners that builds on the preclinical research of the NELL-1 protein. Bone Biologics is focusing development efforts for its bone graft substitute product on bone regeneration in spinal fusion procedures, while additionally having rights to trauma and osteoporosis applications. For more information, please visit
